Patents by Inventor Zhanwu Liu

Zhanwu Liu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human liver regeneration associated protein and the use thereof
    Patent number: 8193162
    Abstract: This invention provides a novel human liver regeneration associated protein hLRTM4 and the polynucleotide which encodes the hLRTM4 protein. Furthermore, this invention provides a method of preparing and using hLRTM4 protein, and its polynucleotides. hLRTM4 protein can be used to treat liver injury, and its antagonists (e.g. antisense nucleic acids and antibodies) can be used to treat hepatocellular carcinoma. This invention also provides the corresponding pharmaceutical compositions.
    Type: Grant
    Filed: April 23, 2010
    Date of Patent: June 5, 2012
    Assignee: Shanghai Institutes for Biological Sciences, CAS
    Inventors: Mujun Zhao, Zhanwu Liu, Jie Qiu, Zaiping Li
  • HUMAN LIVER REGENERATION ASSOCIATED PROTEIN AND THE USE THEREOF
    Publication number: 20100203065
    Abstract: This invention provides a novel human liver regeneration associated protein hLRTM4 and the polynucleotide which encodes the hLRTM4 protein. Furthermore, this invention provides a method of preparing and using hLRTM4 protein, and its polynucleotides. hLRTM4 protein can be used to treat liver injury, and its antagonists (e.g. antisense nucleic acids and antibodies) can be used to treat hepatocellular carcinoma. This invention also provides the corresponding pharmaceutical compositions.
    Type: Application
    Filed: April 23, 2010
    Publication date: August 12, 2010
    Applicant: Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
    Inventors: Mujun Zhao, Zhanwu Liu, Qiu Jie, Zaiping Li
  • Human liver regeneration associated protein and the use thereof
    Patent number: 7741468
    Abstract: This invention provides a novel human liver regeneration associated protein hLRTM4 and the polynucleotide which encodes the hLRTM4 protein. Furthermore, this invention provides a method of preparing and using hLRTM4 protein and its polynucleotides. hLRTM4 protein can be used to treat liver injury, and its antagonists (e.g. antisense nucleic acids and antibodies) can be used to treat hepatocellular carcinoma. This invention also provides the corresponding pharmaceutical compositions.
    Type: Grant
    Filed: December 31, 2003
    Date of Patent: June 22, 2010
    Assignee: Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
    Inventors: Mujun Zhao, Zhanwu Liu, Jie Qiu, Zaiping Li